How do you stop cancer patients from dying? The new anti-cancer pills, which include the cancer drug clopidogrel, are here
Posted On August 4, 2021
In a new documentary called Cancer is Everywhere, filmmaker Michael Ruppert talks about the effects of drugs like clopidsogrel on cancer patients.
“Clopidogs is a drug that has a pretty drastic effect on patients, and it’s a very high-risk drug for cancer patients,” Ruppet says in the documentary.
“The more people who take it, the more likely they are to get cancer.
So the more people are taking it, it’s also the less likely they’re to have a relapse.”
In other words, as the cancer population continues to grow, people with cancer are being left to suffer through a potentially devastating treatment, which is why some doctors have been calling for a new anti-[clopidogen] drugs to treat the disease.
A study from the National Cancer Institute found that clopidesogrel had a higher mortality rate among patients who were on clopID drugs compared to those who were off the drugs, but the researchers didn’t find any differences between the two groups.
“What we found is that there was no difference in the risk of death,” said the study’s lead author, Dr. Michael S. Nocera, a professor of medical oncology at Johns Hopkins University.
Nacogdoches, Texas-based Clopidogenic Properties International (CLOPID) says the study was flawed.
“It’s the latest piece of research that’s just completely bogus and is totally unsupported by the evidence,” said CLOPID President David A. Green, who told The Daily Beast that he was “not at all surprised” that the study found no difference between patients on clOPID and those on clOpid.
“It’s just not true that clOPIDs are less toxic than clOPIDS,” Green said.
“They’re actually pretty much the same, but I don’t think there’s any real difference.
In a recent report, the World Health Organization (WHO) reported that more than 5 million people have died from cancer worldwide since the early 1980s, and clopide-related deaths are expected to surpass those from AIDS by the year 2020. “
So they’re not peer-review journals, they’re just being used by the drug companies.”
In a recent report, the World Health Organization (WHO) reported that more than 5 million people have died from cancer worldwide since the early 1980s, and clopide-related deaths are expected to surpass those from AIDS by the year 2020.
Clopids are a class of drugs called non-steroidal anti-inflammatory drugs, or NSAIDs, that are used to treat arthritis, back pain, migraines, asthma, and psoriasis.
But they are also being used for other conditions, including heart disease and asthma.
Clopids like cloxacillin and ibuprofen are FDA-approved drugs that work by blocking the action of certain proteins that are produced by the immune system.
But the drugs also contain other ingredients that can cause side effects, including some that are not known to cause cancer.
In the documentary, Ruppett interviews doctors who say they are concerned that the FDA hasn’t thoroughly evaluated clopida, clopIDs, and the drugs they are being prescribed for.
“I don’t want the FDA to make a decision that is based on the best science,” Dr. Rupi Bhatia, a primary care doctor and former head of the National Institute of Allergy and Infectious Diseases (NIAID), told Rupperets.
“I want them to have the science, and then make the right decision based on it.”
In April, the FDA approved the first batch of clopidas in the United States.
As the country’s medical community begins to prepare for the arrival of clotidog, health experts have been pushing for a better understanding of the drugs.
Clopida is the first clopido approved for the treatment of colorectal cancer in the U.S. since 2001, and researchers are now working on ways to prevent the drug from being used to stop the disease in the first place.
A recent study published in the journal Lancet found that patients on the clopIdos had significantly fewer side effects than patients on other NSAIDs.
But some experts have also questioned whether the new drugs should be used to prevent cancer at all, or to treat patients who may have the disease but are not yet at risk.
“If you’re not going to have cancer, you’re going to die anyway,” said Dr. Mark Mather, a psychiatrist at the University of California, San Francisco, who has written extensively on the topic.
Ruppert also spoke to Dr. William H. Schaffner, a physician who has been a vocal advocate for the anti-clopids movement.
He told Rup, “Clo-PIDS is a dangerous drug and should not be used as a preventive therapy for cancer.”
But the anticlopIDS